ReviewACS pharmacology & translational science2026

Exploring Galectin‑3 as an Emerging Frontier in Biomarker Research for Clinical Trials Approaching Cardiovascular Diseases.

Luís PerpétuoPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.